What is the recommended pediatric dose of Maltofer oral syrup (iron polymaltose complex) for children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Maltofer Syrup Pediatric Dosing

For treatment of iron deficiency anemia in children, administer iron polymaltose complex (Maltofer syrup) at 3-6 mg/kg/day of elemental iron, given once daily or divided into 1-2 doses, preferably with meals.

Dosing Algorithm

Treatment Dose (Iron Deficiency Anemia)

  • Standard dose: 5-6 mg/kg/day of elemental iron 1, 2
  • Administration: Once daily dosing is effective and improves compliance 1
  • Duration: Continue for 3-4 months to replenish iron stores 1
  • Timing: Give with meals (unlike ferrous salts, iron polymaltose complex absorption is not significantly affected by food and may improve tolerability) 3

Prophylactic Dose (Prevention)

  • Infants 1 month to <2 years: 0.6 mg/kg/dose twice daily 4
  • Children 2-11 years: 15 mg twice daily 4
  • Adolescents 12-17 years: 30 mg twice daily 4

Age-Specific Considerations

Preterm Infants:

  • Start at 2 weeks of age with 5 mg/kg/day to optimize iron status and reduce transfusion needs 5
  • Earlier supplementation (2 weeks vs 4 weeks) significantly reduces red blood cell transfusion requirements 5

Term Infants (6-12 months):

  • Begin iron-fortified cereals at 6 months 6
  • If using medicinal iron: 3 mg/kg/day for treatment 6

Key Clinical Advantages

Tolerability Profile:

  • Gastrointestinal adverse events occur in 26.9% with iron polymaltose complex versus 50.9% with ferrous sulfate (p=0.012) 1
  • Better acceptability scores and lower treatment interruption rates compared to ferrous salts 1, 3

Efficacy:

  • Mean hemoglobin increase of 1.2 g/dL at 1 month and 2.3 g/dL at 4 months 1
  • Comparable efficacy to ferrous sulfate but with superior tolerability 1

Important Caveats

Monitoring:

  • Recheck hemoglobin at 4 weeks; expect ≥1 g/dL increase to confirm response 6
  • If no response after 4 weeks despite compliance, evaluate for other causes of anemia 6
  • Continue treatment for 2-3 months after hemoglobin normalizes to replenish stores 6

Dosing Nuance:

  • Iron polymaltose complex may require slightly higher doses than ferrous salts due to different absorption kinetics 3
  • The 5-6 mg/kg/day range is well-established in pediatric trials 1, 2, 5

Safety Consideration:

  • Iron polymaltose complex has a better safety profile in accidental overdose compared to ferrous salts 7
  • This is particularly relevant given that iron overdose can be lethal in children 7

Practical Administration

  • Syrup formulation: Allows precise weight-based dosing in young children
  • With meals: Improves tolerability without compromising absorption 3
  • Vitamin C: Consider co-administering vitamin C-rich foods/juice to enhance absorption 6
  • Avoid: Cow's milk within 1-2 hours of dosing (inhibits absorption)

Note: The evidence provided focuses on parenteral iron and trace minerals [@1-10@], which is not applicable to oral Maltofer syrup dosing. The research evidence [@14-22@] provides the most relevant guidance for oral iron polymaltose complex in pediatric patients.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.